Diagnos Laboratorium Utama PT Tbk (DGNS) — Cash Flow Quality Index
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Cash Flow Quality Index of 3.53x as of June 2024. Operating cash flow of Rp3.32 Billion exceeds net income of Rp940.04 Million, indicating high earnings quality where cash backs reported profits. Explore Diagnos Laboratorium Utama PT Tbk (DGNS) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Diagnos Laboratorium Utama PT Tbk Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for Diagnos Laboratorium Utama PT Tbk across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Diagnos Laboratorium Utama PT Tbk cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Diagnos Laboratorium Utama PT Tbk (2017–2024)
Year-by-year earnings quality comparison for Diagnos Laboratorium Utama PT Tbk. For live market cap and the full company financial profile, see DGNS stock market capitalisation.
| Year | Quality Index | Operating CF (IDR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 36.52x | Rp27.30 Billion | Rp747.44 Million | ▲ +7788.8% |
| 2022 | -0.48x | Rp-6.02 Billion | Rp12.66 Billion | ▼ -151.9% |
| 2021 | 0.92x | Rp58.87 Billion | Rp64.30 Billion | ▲ +83.9% |
| 2020 | 0.50x | Rp26.23 Billion | Rp52.69 Billion | ▼ -58.8% |
| 2019 | 1.21x | Rp11.20 Billion | Rp9.27 Billion | ▲ +32.1% |
| 2018 | 0.91x | Rp8.47 Billion | Rp9.26 Billion | ▲ +277.4% |
| 2017 | -0.52x | Rp-712.00 Million | Rp1.38 Billion | — |